-- カンナラ・バイオテック（LOVE.TO）は水曜日、BZAM Ltd.傘下のメディカン・オーガニックを280万ドルで買収する契約を締結した。 同社は、この買収により、2021年6月8日にメディカンから買収したバレーフィールドの栽培・製造施設の買収が完了したと発表した。 また、同社はニコラス・ソシアック氏を最高執行責任者（COO）に任命した。就任は4月23日付。2020年から最高財務責任者（CFO）を務めてきたソシアック氏は、後任のCFOが見つかるまでの間、COOとして正式に業務に就く。後任探しが完了するまでの間、ソシアック氏は暫定CFOを務める。 同社の株価はトロント証券取引所で0.03ドル高の1.78ドルで取引されている。
Price: $1.78, Change: $+0.03, Percent Change: +1.71%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:RUN reported Q1 sales of $722M (+43% Y/Y), beating consensus estimates of ~$639M, though we view this as largely an accounting presentation issue rather than fundamental business acceleration. Operational metrics show significant volume declines with storage capacity installed (282 MWh, -15% Y/Y), solar capacity (154 MW, -19% Y/Y), and subscriber additions (17,665, -25% Y/Y) all declining. We view RUN's storage-first positioning as strategic for long-term distributed energy opportunities, with storage attachment rate reaching a record 73% (+400 bps Y/Y), though monetization remains in early innings. Management maintained 2026 cash generation guidance of $250M-$450M despite Q1 cash burn of $59M (vs. +$56M in Q1 2025). We view the improvement in net subscriber value to $11,892 (+14% Y/Y) as encouraging, driven by larger system sizes and lower cost of capital, but broader industry headwinds are playing an increasingly significant role.
Fastly (FSLY) reported Q1 adjusted earnings late Wednesday of $0.13 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.08.Revenue in the three months ended March 31 rose to $173 million from $144.5 million a year earlier.Analysts surveyed by FactSet expected $171.8 million.Fastly expects Q2 non-GAAP net income of $0.05 to $0.08 a share on revenue of $170 million to $176 million. Analysts polled by FactSet project EPS of $0.04 on revenue of $169.8 million.The company expects full-year non-GAAP net income of $0.27 to $0.33 a share on revenue of $710 million to $725 million. Analysts project EPS of $0.27 on revenue of $712 million.Fastly shares tumbled 28% in after-hours trading.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FTNT delivered exceptional Q1 2026 results with revenue of $1.85B beating consensus by $120M and non-GAAP EPS of $0.82 exceeding estimates by $0.20. Product revenue accelerated to $645M (+40.5% Y/Y) significantly outpacing service revenue growth of 11%, while billings surged 30.5% to $2.09B. The robust appliance demand suggests active security infrastructure refreshes, though we highlight potential pulled-forward demand amid supply chain challenges and higher memory prices. Operating leverage remained strong with non-GAAP operating margin expanding 160 bps to 36%, while record cash generation of $1.08B in operating cash flow underscores the business model's strength. We expect the SASE evolution and "SASE Firewall" convergence to serve as key differentiators in the competitive landscape. Management raised 2026 revenue guidance to $7.71B-$7.87B from $7.50B-$7.70B, above consensus of $7.6B, and lifted EPS guidance to $3.10-$3.16 from $2.94-$3.00, beating Street forecasts of $3.00.